Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01402180 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy(Nimotuzumab) | unknown | Phase 2 / Phase 3 | 128 | Fudan UniversityOTHER | 1 | Jul 26, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK |
| 1 |
| Jul 25, 2011 |
| clinicaltrials |
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | unknown | Phase 2 | 300 | Fudan UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00051480 | Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT01336049 | Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Peking UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00578201 | FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer(FOLFOX) | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 31, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00060268 | Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors | completed | Phase 1 / Phase 2 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 9, 2011 | clinicaltrials |
| NCT01144325 | Minimally Invasive Esophagectomy (MIE) in Prone Versus Left Decubitus Position | unknown | Phase 2 | 2 | Fudan UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma(EXCEL) | completed | Phase 2 | 55 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01291823 | Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer | unknown | Phase 2 | 70 | Zhejiang Cancer HospitalOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01267578 | Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00669292 | PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer | unknown | Phase 1 / Phase 2 | 29 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | unknown | Phase 1 / Phase 2 | 32 | Wakayama Medical UniversityOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00453323 | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | unknown | Phase 2 | 33 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | completed | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01034332 | Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer | unknown | Phase 2 | 58 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT01034189 | Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer | unknown | Phase 2 | 62 | National Taiwan University HospitalOTHER | 1 | Dec 17, 2009 | clinicaltrials |
| NCT00066716 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | completed | Phase 2 | 39 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT00681330 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00995358 | A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | completed | Phase 2 | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | completed | Phase 2 | 33 | Hamamatsu UniversityOTHER | 1 | Feb 20, 2009 | clinicaltrials |
| NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer(CONKO-101) | completed | Phase 2 | 92 | CONKO-StudiengruppeOTHER | 1 | Sep 26, 2008 | clinicaltrials |
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | terminated | Phase 2 | 29 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | unknown | Phase 2 | 100 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00477841 | Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer | completed | Phase 2 | 60 | Southeast University, ChinaOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00154804 | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 23, 2007 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
| NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2005 | clinicaltrials |
| NCT00139633 | Selective Dose Escalation for Esophageal Cancer | unknown | Phase 2 | 25 | The Oregon ClinicOTHER | 1 | Aug 31, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 26, 2011source: clinicaltrials